pac.dog pac.dog / Bills

SB 598Requires certain health insurance providers to ensure that coverage for a nonopioid prescription drug is available as an alternative for an opioid prescription drug and to use the same utilization review requirements and cost-sharing provisions for opioid and nonopioid drugs when they are prescribed for the same treatment.

Congress · introduced 2024-12-31

Digest: Tells some health insurers to cover a nonopioid drug alternate for an opioid drug with the same rules. Tells the PTC to add to their suggestions a nonopioid drug alternate for an opioid drug with the same rules. (Flesch Readability Score: 60.6). Requires certain health insurance providers to ensure that coverage for a nonopioid prescription drug is available as an alternative for an opioid prescription drug and to use the same utilization review requirements and cost-sharing provisions for opioid and nonopioid drugs when they are prescribed for the same treatment. Requires the Pharmacy and Therapeutics Committee to include nonopioid prescription drug alternatives to opioid prescription drugs with the same utilization review requirements when making recommendations to the Oregon Health Authority for the preferred drug list and Practitioner-Managed Prescription Drug Plan.

Latest action: Chapter Number Assigned

Sponsors

Action timeline

No actions on file yet — BILLSTATUS ingest fills this for every bill currently in the index. Run npm run db:ingest -- --source=bill-status --congress= to pull this bill's actions on demand.

Text versions

No text versions on file yet — same ingest as the action timeline populates these. Each version has direct links to the XML / HTML / PDF at govinfo.gov.

Connected on the graph

Inbound (7)

datefromtypeamountrolesource
2024-12-31Chotzen, Willycosponsor_of_billcosponsorsponsorship
2024-12-31Grayber, Daciacosponsor_of_billcosponsorsponsorship
2024-12-31Levy, Emersoncosponsor_of_billcosponsorsponsorship
2024-12-31Nelson, Traviscosponsor_of_billcosponsorsponsorship
2024-12-31Nosse, Robcosponsor_of_billcosponsorsponsorship
2024-12-31Campos, Wlnsveysponsor_of_billsponsorsponsorship
2024-12-31Patterson, Debcosponsor_of_billcosponsorsponsorship

Who matters

Members ranked by combined influence on this bill: role (sponsor 5 / cosponsor 1), capped speech count from the Congressional Record, and recorded-vote engagement.

#MemberRoleSpeechesVotedScore
1Campos, Wlnsvey (D, state_upper OR-18)sponsor05
2Chotzen, Willy (D, state_lower OR-46)cosponsor01
3Grayber, Dacia (D, state_lower OR-28)cosponsor01
4Levy, Emerson (D, state_lower OR-53)cosponsor01
5Nelson, Travis (D, state_lower OR-44)cosponsor01
6Nosse, Rob (D, state_lower OR-42)cosponsor01
7Patterson, Deb (D, state_upper OR-10)cosponsor01

Predicted vote

Aggregated from: actual roll-call votes (when present) → sponsor → cosponsor → party median (predicts YES when ≥25% of the caucus sponsored/cosponsored). Each row labels its confidence tier so you can see why a position was predicted.

0 predicted yes (0%) · 543 predicted no (100%) · 0 unknown (0%)

By party: · R: 0 yes / 277 no · D: 0 yes / 263 no · I: 0 yes / 3 no

Activity

Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.

  1. 2024-12-31 · cosponsored by Patterson, Deb (cosponsor) · sponsorship
  2. 2024-12-31 · sponsored by Campos, Wlnsvey (sponsor) · sponsorship
  3. 2024-12-31 · cosponsored by Levy, Emerson (cosponsor) · sponsorship
  4. 2024-12-31 · cosponsored by Chotzen, Willy (cosponsor) · sponsorship
  5. 2024-12-31 · cosponsored by Grayber, Dacia (cosponsor) · sponsorship
  6. 2024-12-31 · cosponsored by Nosse, Rob (cosponsor) · sponsorship
  7. 2024-12-31 · cosponsored by Nelson, Travis (cosponsor) · sponsorship

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.

Estimated value: $180/mo per user — but we made it free.